Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Embecta Corp. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Embecta securities between November 25, 2025 and May 4, 2026. The complaint claims the company made false and misleading statements about its business, including describing its pen needle business as incredibly resolute shortly before missing expectations and cutting fiscal 2026 guidance. On May 5, 2026, Embecta reported a revenue decline of over 14%, far worse than its guidance of flat to a 2% decline, and lowered its outlook due in part to weakness in pen needle sales. Investors have until August 17, 2026 to seek lead plaintiff appointment.
Embecta CorpClass action lawsuit alleging securities law violations and false statements about pen needle business.